Geode Capital Management
CNTB

Geode Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Geode Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.2K Buy
32,129
+8,809
+38% +$23K ﹤0.01% 4174
2025
Q4 		$65.8K Hold
23,320
– – ﹤0.01% 4187
2025
Q3 		$34.5K Hold
23,320
– – ﹤0.01% 4361
2025
Q2 		$23.3K Sell
23,320
-4,641
-17% -$3.7K ﹤0.01% 4341
2025
Q1 		$15.4K Hold
27,961
– – ﹤0.01% 4396
2024
Q4 		$38.6K Hold
27,961
– – ﹤0.01% 4283
2024
Q3 		$39.7K Hold
27,961
– – ﹤0.01% 4306
2024
Q2 		$42.5K Hold
27,961
– – ﹤0.01% 4313
2024
Q1 		$48.7K Hold
27,961
– – ﹤0.01% 4329
2023
Q4 		$33K Buy
27,961
+8,929
+47% +$10.6K ﹤0.01% 4439
2023
Q3 		$14.8K Hold
19,032
– – ﹤0.01% 4672
2023
Q2 		$21.1K Hold
19,032
– – ﹤0.01% 4652
2023
Q1 		$19K Hold
19,032
– – ﹤0.01% 4707
2022
Q4 		$16K Hold
19,032
– – ﹤0.01% 4791
2022
Q3 		$24K Hold
19,032
– – ﹤0.01% 4889
2022
Q2 		$16K Hold
19,032
– – ﹤0.01% 4952
2022
Q1 		$57K Buy
+19,032
New +$80.3K ﹤0.01% 4783

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Geode Capital Management's CNTB Position: Q1 2026 in Review

Geode Capital Management increased its Connect Biopharma Holdings (CNTB) stake by 38% in Q1 2026, buying an estimated $23K and bringing the position to 32,129 shares worth $84.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4174.

Geode Capital Management first reported a position in CNTB in Q1 2022 and has held it in 17 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Geode Capital Management held 32,129 shares of Connect Biopharma Holdings worth $84.2K as of Q1 2026.
  • Geode Capital Management bought 8,809 Connect Biopharma Holdings shares in Q1 2026, an estimated $23K.
  • Connect Biopharma Holdings made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4174 holding.
  • Geode Capital Management first reported a position in Connect Biopharma Holdings in Q1 2022 and has held it in 17 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.